Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)
| 24.53 Delayed Data As of Dec 07 |  +0.74 / +3.11%Today’s Change | 20.67 Today|||52-Week Range 42.48 | -39.52% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 382.0K | 158.3K | 31.4M | 16.1M | |
| Depreciation And Amortization | 2.3M | 3.3M | 4.7M | 4.7M | ||
| Operating Expenses | Gross Income | -- | -- | -- | -- | -- |
| General Expenses | 82.0M | 82.5M | 63.7M | 67.4M | ||
| Research And Development | 47.3M | 41.5M | 31.7M | 48.3M | ||
| Total Operating Expenses | 84.3M | 85.7M | 68.4M | 72.1M | ||
| Non-Operating Expenses | Operating Income | -83.9M | -85.6M | -37.0M | -55.9M | |
| Extraordinary Credit | 2.9M | 5.9M | 2.2M | 432.1K | ||
| Extraordinary Charge | -12.0M | -2.4M | 0.00 | 0.00 | ||
| Other Expenses | 437.1K | 57.4K | 0.00 | 7.5K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -91.9M | -81.7M | -34.4M | -54.4M | |
| Income Taxes | -2.4K | -2.4K | -2.4K | -2.4K | ||
| Net Income | -91.9M | -81.7M | -34.4M | -54.5M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 57.4M | 61.1M | 73.9M | 83.6M | |
| Shares To Calculate EPS Diluted | 57.4M | 61.1M | 73.9M | 83.6M | ||
| Earnings Per Share | EPS | -$1.60 | -$1.34 | -$0.47 | -$0.65 | |
| EPS Diluted | -$1.60 | -$1.34 | -$0.47 | -$0.65 | ||
